|
1
|
Rivera C: Essentials of oral cancer. Int J
Clin Exp Pathol. 8:11884–11894. 2015.PubMed/NCBI
|
|
2
|
Mehanna H, Paleri V, West CM and Nutting
C: Head and neck cancer-part 1: Epidemiology, presentation and
preservation. Clin Otolaryngol. 36:65–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dhanuthai K, Rojanawatsirivej S, Thosaporn
W, Kintarak S, Subarnbhesaj A, Darling M, Kryshtalskyj E, Chiang
CP, Shin HI, Choi SY, et al: Oral cancer: A multicenter study. Med
Oral Patol Oral Cir Bucal. 23:e23–e29. 2018.PubMed/NCBI
|
|
4
|
Lingen MW, Kalmar JR, Karrison T and
Speight PM: Critical evaluation of diagnostic aids for the
detection of oral cancer. Oral Oncol. 44:10–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harada K, Ferdous T, Horinaga D, Uchida K,
Mano T, Mishima K, Park S, Hanazawa H, Takahashi S, Okita A, et al:
Efficacy of elemental diet on prevention for
chemoradiotherapy-induced oral mucositis in patients with oral
squamous cell carcinoma. Support Care Cancer. 24:953–959. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sonis ST: Oral mucositis. Anticancer
Drugs. 22:607–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moslemi D, Nokhandani AM, Otaghsaraei MT,
Moghadamnia Y, Kazemi S and Moghadamnia AA: Management of
chemo/radiation-induced oral mucositis in patients with head and
neck cancer: A review of the current literature. Radiother Oncol.
120:13–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gutiérrez-Vargas R, Díaz-García ML,
Villasís-Keever MÁ, Portilla-Robertson J and Zapata-Tárres M:
Instruments to measure the quality of life in patients with oral
mucositis undergoing oncological treatment: A systematic review of
the literature. Bol Med Hosp Infant Mex. 73:457–466.
2016.PubMed/NCBI
|
|
9
|
Lalla RV, Sonis ST and Peterson DE:
Management of oral mucositis in patients who have cancer. Dent Clin
North Am. 52:61–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bese NS, Hendry J and Jeremic B: Effects
of prolongation of overall treatment time due to unplanned
interruptions during radiotherapy of different tumor sites and
practical methods for compensation. Int J Radiat Oncol Biol Phys.
68:654–661. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Russo G, Haddad R, Posner M and Machtay M:
Radiation treatment breaks and ulcerative mucositis in head and
neck cancer. Oncologist. 13:886–898. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sonis ST, Oster G, Fuchs H, Bellm L,
Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque
FG, et al: Oral mucositis and the clinical and economic outcomes of
hematopoietic stem-cell transplantation. J Clin Oncol.
19:2201–2205. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bressan V, Stevanin S, Bianchi M, Aleo G,
Bagnasco A and Sasso L: The effects of swallowing disorders,
dysgeusia, oral mucositis and xerostomia on nutritional status,
oral intake and weight loss in head and neck cancer patients: A
systematic review. Cancer Treat Rev. 45:105–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Henke M, Alfonsi M, Foa P, Giralt J,
Bardet E, Cerezo L, Salzwimmer M, Lizambri R, Emmerson L, Chen MG
and Berger D: Palifermin decreases severe oral mucositis of
patients undergoing postoperative radiochemotherapy for head and
neck cancer: A randomized, placebo-controlled trial. J Clin Oncol.
29:2815–2820. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Svanberg A, Ohrn K and Birgegard G: Oral
cryotherapy reduces mucositis and improves nutrition-a randomised
controlled trial. J Clin Nurs. 19:2146–2151. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scully C, Epstein J and Sonis S: Oral
mucositis: A challenging complication of radiotherapy, chemotherapy
and radiochemotherapy. Part 2: Diagnosis and management of
mucositis. Head Neck. 26:77–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cowen D, Tardieu C, Schubert M, Peterson
D, Resbeut M, Faucher C and Franquin JC: Low energy helium-neon
laser in the prevention of oral mucositis in patients undergoing
bone marrow transplant: Results of a double blind randomized trial.
Int J Radiat Oncol Biol Phys. 38:697–703. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng KK, Molassiotis A, Chang AM, Wai WC
and Cheung SS: Evaluation of an oral care protocol intervention in
the prevention of chemotherapy-induced oral mucositis in paediatric
cancer patients. Eur J Cancer. 37:2056–2063. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Online EA Pharma Co. Ltd Products
Information, Elental®, . http://www.eapharma.co.jp/medicalexpert/product/elental/elental_information.htmlWebpage
in Japanese. August 19–2017
|
|
20
|
Ikeura T, Takaoka M, Uchida K, Miyoshi H
and Okazaki K: Beneficial effect of low-fat elemental diet therapy
on pain in chronic pancreatitis. Int J Chronic Dis.
2014:8620912014.PubMed/NCBI
|
|
21
|
Nakayama G, Morioka D, Murakami T,
Takakura H, Miura Y and Togo S: Chylous ascites occurring after low
anterior resection of the rectum successfully treated with an oral
fat-free elemental diet (Elental®). Clin J
Gastroenterol. 5:216–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gaurav K, Goel RK, Shukla M and Pandey M:
Glutamine: A novel approach to chemotherapy-induced toxicity.
Indian J Med Paediatr Oncol. 33:13–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okada T, Nakajima Y, Nishikage T,
Ryotokuji T, Miyawaki Y, Hoshino A, Tokairin Y, Kawada K, Nagai K
and Kawano T: A prospective study of nutritional supplementation
for preventing oral mucositis in cancer patients receiving
chemotherapy. Asia Pac J Clin Nutr. 26:42–48. 2017.PubMed/NCBI
|
|
24
|
Choi K, Lee SS, Oh SJ, Lim SY, Lim SY,
Jeon WK, Oh TY and Kim JW: The effect of oral glutamine on
5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by
intestinal permeability test. Clin Nutr. 26:57–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Savarese DM, Savy G, Vahdat L, Wischmeyer
PE and Corey B: Prevention of chemotherapy and radiation toxicity
with glutamine. Cancer Treat Rev. 29:501–513. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamamoto T, Nakahigashi M, Umegae S,
Kitagawa T and Matsumoto K: Acute duodenal Crohn's disease
successfully managed with low-speed elemental diet infusion via
nasogastric tube: A case report. World J Gastroenterol. 12:649–651.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamamoto T, Nakahigashi M, Umegae S,
Kitagawa T and Matsumoto K: Impact of elemental diet on mucosal
inflammation in patients with active Crohn's disease: Cytokine
production and endoscopic and histological findings. Inflamm Bowel
Dis. 11:580–588. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ogata Y, Takeuchi M, Ishibashi N, Kibe S,
Takahashi K, Uchida S, Murakami N, Yahara T and Shirouzu K:
Efficacy of Elental on prevention for chemotherapy-induced oral
mucositis in colorectal cancer patients. Gan To Kagaku Ryoho.
39:583–587. 2012.(In Japanese). PubMed/NCBI
|
|
29
|
Fukui T, Itoh Y, Orihara M, Yoshizawa K,
Takeda H, Kawada S and Yoshioka T: Elental prevented and reduced
oral mucositis during chemotherapy in patients esophageal cancer.
Gan To Kagaku Ryoho. 38:2597–2601. 2011.(In Japanese). PubMed/NCBI
|
|
30
|
Ishikawa T, Yasuda T, Doi T, Okayama T,
Sakamoto N, Gen Y, Dohi O, Yoshida N, Kamada K, Uchiyama K, et al:
The amino acid-rich elemental diet Elental® preserves
lean body mass during chemo- or chemoradiotherapy for esophageal
cancer. Oncol Rep. 36:1093–1100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bieri S, Bentzen SM, Huguenin P, Allal AS,
Cozzi L, Landmann C, Monney M and Bernier J: Early morbidity after
radiotherapy with or without chemotherapy in advanced head and neck
cancer. Experience from four nonrandomized studies. Strahlenther
Onkol. 179:390–395. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cooper JS, Pajak TF, Forastiere AA, Jacobs
J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et
al: Postoperative concurrent radiotherapy and chemotherapy for
high-risk squamous-cell carcinoma of the head and neck. N Engl J
Med. 350:1937–1944. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Van den Berg MG, Rasmussen-Conrad EL,
Gwasara GM, Krabbe PF, Naber AH and Merkx MA: A prospective study
on weight loss and energy intake in patients with head and neck
cancer, during diagnosis, treatment and revalidation. Clin Nutr.
25:765–772. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ganzer H, Rothpletz-Puglia P, Byham-Gray
L, Murphy BA and Touger-Decker R: The eating experience in
long-term survivors of head and neck cancer: A mixed-methods study.
Support Care Cancer. 23:3257–3268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sornsuvit C, Komindr S, Chuncharunee S,
Wanikiat P, Archararit N and Santanirand P: Pilot study: Effects of
parenteral glutamine dipeptide supplementation on neutrophil
functions and prevention of chemotherapy-induced side-effects in
acute myeloid leukaemia patients. J Int Med Res. 36:1383–1391.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maeda A, Ando H, Ura T, Komori A, Hasegawa
A, Taniguchi H, Kadowaki S, Muro K, Tajika M, Kobara M, et al:
Association between ABCG2 and SLCO1B1 polymorphisms and adverse
drug reactions to regorafenib: A preliminary study. Int J Clin
Pharmacol Ther. 55:409–415. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Harada K, Ferdous T, Kobayashi H and
Ueyama Y: Elemental diet accelerates the recovery from oral
mucositis and dermatitis induced by 5-Fluorouracil through the
induction of fibroblast growth factor 2. Integr Cancer Ther.
17:423–430. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Online Nestle Products Information.
VIVONEX® T.E.N. https://www.nestlehealthscience.us/brands/vivonex/vivonex-t-e-nMarch
1–2018
|
|
39
|
Yamamoto T, Shiraki M, Nakahigashi M,
Umegae S and Matsumoto K: Enteral nutrition to suppress
postoperative Crohn's disease recurrence: A five-year prospective
cohort study. Int J Colorectal Dis. 28:335–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takagi S, Utsunomiya K, Kuriyama S,
Yokoyama H, Takahashi S, Iwabuchi M, Takahashi H, Takahashi S,
Kinouchi Y, Hiwatashi N, et al: Effectiveness of an ‘half elemental
diet’ as maintenance therapy for Crohn's disease: A
randomized-controlled trial. Aliment Pharmacol Ther. 24:1333–1340.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bossi P, Locati LD and Licitra L:
Palifermin in prevention of head and neck cancer radiation-induced
mucositis: Not yet a definitive word on safety and efficacy
profile. J Clin Oncol. 30:565–567. 2012. View Article : Google Scholar
|
|
42
|
Ogata Y, Ishibashi N, Yamaguchi K, Uchida
S, Kamei H, Nakayama G, Hirakawa H, Tanigawa M and Akagi Y:
Preventive effects of amino-acid-rich elemental diet
Elental® on chemotherapy-induced oral mucositis in
patients with colorectal cancer: A prospective pilot study. Support
Care Cancer. 24:783–789. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Harada K, Ferdous T, Mizukami Y and
Mishima K: Elemental diet inhibits pro-inflammatory cytokine
production in keratinocytes through the suppression of NF-κB
activation. Oncol Rep. 40:361–368. 2018.PubMed/NCBI
|
